In the latest trading session,, 3.38 million Lexeo Therapeutics Inc (NASDAQ:LXEO) shares changed hands as the company’s beta touched 2.86. With the company’s most recent per share price at $9.30 changing hands around $1.61 or 20.87% at last look, the market valuation stands at $307.30M. LXEO’s current price is a discount, trading about -140.11% off its 52-week high of $22.33. The share price had its 52-week low at $7.47, which suggests the last value was 19.68% up since then. When we look at Lexeo Therapeutics Inc’s average trading volume, we note the 10-day average is 0.31 million shares, with the 3-month average coming to 288.80K.
Analysts gave the Lexeo Therapeutics Inc (LXEO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.14. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LXEO as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Lexeo Therapeutics Inc’s EPS for the current quarter is expected to be -0.68.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Lexeo Therapeutics Inc (NASDAQ:LXEO) trade information
Instantly LXEO is in green as seen in intraday trades today. With action 13.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -30.74%, with the 5-day performance at 13.35% in the green. However, in the 30-day time frame, Lexeo Therapeutics Inc (NASDAQ:LXEO) is 4.09% up. Looking at the short shares, we see there were 2.19 million shares sold at short interest cover period of 6.55 days.
The consensus price target for the stock as assigned by Wall Street analysts is 28, meaning bulls need an upside of 66.79% from its recent market value. According to analyst projections, LXEO’s forecast low is 28 with 28 as the target high. To hit the forecast high, the stock’s price needs a -201.08% plunge from its current level, while the stock would need to soar -201.08% for it to hit the projected low.
Lexeo Therapeutics Inc (LXEO) estimates and forecasts
Data shows that the Lexeo Therapeutics Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -33.42% over the past 6 months, a 77.74% in annual growth rate that is considerably higher than the industry average of 16.40%.
The 2024 estimates are for Lexeo Therapeutics Inc earnings to increase by 77.69%.
LXEO Dividends
Lexeo Therapeutics Inc is expected to release its next quarterly earnings report on 2024-Aug-12.
